Trending stocks today
Moderna (MRNA-Q)
NASDAQ:MRNA
76.24
1.46
(1.88%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Related posts
Markets rally to strongest week this yearYields and TSX climb, Wall Street flatEarnings optimism lifts markets
A good mix of consumer goods and healthcare, but the PE is extended. Prefers to buy Pfizer for its growth and lower PE. He might even roll the dice with Moderna. Or buy the IBB, biotech ETF.
Down 26% in the last 23 months. It's suffering a post-Covid hangover and the company is better than this.
Is down 22% in the last 3 months. But he would but it. They're out of fashion, sure, and it's considered a Covid name, but their science is very good. A personalized cancer vaccine is possible.
They have developed a vaccine template that will benefit them going forward. Do not sell, but add more.
In past years, biotech was the safe trade, but this year risk is back, so these stocks have fallen out of favour. Also, there are so many drugs in trials now and big pharma needs new product. She's looking at Gilead and Moderna, because they have low PEs and alot of drugs in development. However, the overall sector is risky.
They're holding an investor event on Monday. They delivered an early Covid vaccine, but shares have fallen since then. A smart CEO. They're working on a personalized cancer medication.
The risk/return is elevated so be careful.
The stock price has been impacted by news of reduced sales of its COVID19 vaccine. This is to be expected as governments draw down their previously purchased inventory and uptake slows with re-opening. COVID is not going away anytime soon with booster shots expected in the fall. Recently reported earnings beat expectation, showing a gain when analysts expected a loss. The company is also working on a RSV vaccine. It trades at 7x earnings and supports a ROE of 50%. We recommend placing a stop loss at $100, looking to achieve $199 -- upside potential of 45%. Yield 0%
(Analysts’ price target is $198.77)Hold it and put it away. It is event-driven. Their cancer vaccine data is coming, for instance, and will do well. This is a long-term buy.
Likes it long term. They will reveal data on a personalized cancer vaccine coming up. But short term it's volatile, anybody's guess.
Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA. Social media mentions are up 160% in the past 24h.
$145.790
Unknown
Moderna(MRNA-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 8
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 9
Moderna(MRNA-Q) Frequently Asked Questions
What is Moderna stock symbol?
Moderna is a American stock, trading under the symbol MRNA-Q on the NASDAQ (MRNA). It is usually referred to as NASDAQ:MRNA or MRNA-Q
Is Moderna a buy or a sell?
In the last year, 9 stock analysts published opinions about MRNA-Q. 8 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Moderna.
Is Moderna a good investment or a top pick?
Moderna was recommended as a Top Pick by on . Read the latest stock experts ratings for Moderna.
Why is Moderna stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Moderna worth watching?
9 stock analysts on Stockchase covered Moderna In the last year. It is a trending stock that is worth watching.
What is Moderna stock price?
On 2023-12-01, Moderna (MRNA-Q) stock closed at a price of $76.24.
Covid vaccine was its first commercial product, and it did well. That's trailing off. Investing in drug pipeline, and it's hard to determine when products might be approved and launched. Her preference is a more established company with a pipeline.